News & Reports 2017-04-05T16:38:50+00:00

Have some news you want to share with the Oregon Bio community?  Fill out our submission form.

Governor Kate Brown to Launch Bio Researchers’ and Entrepreneurs’ Sessions at the Oregon Bioscience Showcase


The first-ever appearance by an Oregon Governor at the entrepreneurs’ event will highlight the researchers’ fast pitch and the company showcase #OregonBio2017

CONTACT: Denise McCarty, Executive Director, (503) 548-4432
Dianne Danowski Smith, Board member, (503) 201-7019, @OregonBio

(Portland, Ore.)  – Attendees at the Oregon Bioscience Showcase will hear from Governor Kate Brown (@OregonGovBrown) as she launches […]

October 17th, 2017|

Portland-Based Immuno-oncologist Dr. Bernard A. Fox To Present at Siena, Italy Conference

October 7, 2017
Contact: Patricia Pearson,

Siena, Italy—Dr. Bernard A. Fox, internationally known expert in immuno-oncology will meet with other cancer experts here Saturday to discuss recent advances in treatmentsthat hold promise for improved treatments and increased survival for patients with cancer. Dr. Fox, chief executive officer, UbiVac,, will discuss the latest research in agonistic antibodies in an era of antagonistic antibodies. He will provide insights into mono-therapy, as well as […]

October 13th, 2017|

Oregon’s Life Science Industry on Display: Oregon Bioscience Showcase 2017

The first-ever Oregon Bioscience Showcase, on October 30, combines the Research Fast Pitch and Company Pitch Showcase, presenting emerging companies and rising-star researchers #OregonBio2017

CONTACT: Denise McCarty, Executive Director, (503) 548-4432
Dianne Danowski Smith, Board member, (503) 201-7019, @OregonBio

(Portland, Ore.)  – Three minutes. That’s all the time nine local researchers and students will have to showcase their research and projects to a room full of bioscience professionals, enthusiasts and judges. This is their unique […]

September 21st, 2017|

Why UO’s Knight Campus will boost Oregon’s fortunes (guest column)

The $1B project still needs lawmakers to approve $100M in bonds, an investment its new director says will bring together the whole state.

Patrick Phillips

The University of Oregon will break ground on the $1 billion Phil and Penny Knight Campus for Accelerating Scientific Impact this fall —made possible by a $500 million donation from the Knights — and the labs, classrooms, prototyping space and other core facilities will be the foundation for new scientific activities that […]

June 23rd, 2017|

Portland biotech startup foresees rapid growth from HIV test

Elizabeth Hayes, Staff Reporter, Portland Business Journal

Typically, an HIV diagnostic test takes a few hours to run and requires a laboratory.

A Portland biosciences company is developing a hand-held test that can produce accurate results from a drop of blood in just 20 minutes — and estimate how recently the infection occurred.

Sedia Biosciences Corp.’s rapid HIV test could potentially speed up diagnosis of the disease, especially in developing countries, and play a big role in slowing […]

June 21st, 2017|


Emerging biotech Mebias Discovery presented preclinical data showing its mu opioid candidates could become a weapon in the scramble to combat the opioid epidemic. [...]

The bipartisan deal to stabilize ObamaCare's markets has 24 co-sponsors, Senate Health Committee Chairman Lamar Alexander (R-Tenn.) announced Thursday.Twelve Republicans and 12 Democrats signed o [...]

Burnout and stress impact healthcare workers at all levels, but for nurses it can lead to lapses in the quality of care they provide. Nurses can take steps to protect their well-being, and the safety [...]

Despite an increase in the number of bilingual physicians in the United States, in many places there's still a big gap between the languages that patients speak and those of their doctors. Some a [...]

UnitedHealth, fresh off a victory in a fraud case the government brought against it, has filed a motion in a separate case to ask a federal judge to throw out a Medicare Advantage overpayment rule. Th [...]

Adding to requests to Merck and HHS, Rep. Greg Walden, R-Ore., has asked the software company Nuance to provide more information about the NotPetya malware attack that shut down transcription applicat [...]

A little over a month after Johnson & Johnson pulled the plug on its hepatitis C pipeline and said it would focus on hepatitis B, the Big Pharma's biotech unit has notched a deal with Arcturu [...]

Highmark Health's Allegheny Health Network will invest $1 billion to build a new state-of-the-art hospital and new "neighborhood hospitals" and to renovate existing hospitals. [...]